SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-108364
Filing Date
2017-04-03
Accepted
2017-04-03 15:22:34
Documents
3
Period of Report
2017-04-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d371260d8k.htm 8-K 15615
2 EX-99.1 d371260dex991.htm EX-99.1 120970
3 GRAPHIC g371260logo.jpg GRAPHIC 13843
  Complete submission text file 0001193125-17-108364.txt   156928
Mailing Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044
Business Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044 602-910-2617
Insys Therapeutics, Inc. (Filer) CIK: 0001516479 (see all company filings)

IRS No.: 510327886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35902 | Film No.: 17733807
SIC: 2834 Pharmaceutical Preparations